Evolus Statistics
Total Valuation
Evolus has a market cap or net worth of $1.04 billion. The enterprise value is $1.07 billion.
Important Dates
The next estimated earnings date is Tuesday, November 5, 2024, after market close.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Evolus has 63.09 million shares outstanding. The number of shares has increased by 4.41% in one year.
| Shares Outstanding | 63.09M |
| Shares Change (YoY) | +4.41% |
| Shares Change (QoQ) | +6.68% |
| Owned by Insiders (%) | 1.98% |
| Owned by Institutions (%) | 67.05% |
| Float | 44.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.08 |
| Forward PS | n/a |
| PB Ratio | 53.67 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.92, with a Debt / Equity ratio of 6.56.
| Current Ratio | 2.92 |
| Quick Ratio | 2.53 |
| Debt / Equity | 6.56 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.75 |
Financial Efficiency
Return on equity (ROE) is -861.68% and return on invested capital (ROIC) is -15.98%.
| Return on Equity (ROE) | -861.68% |
| Return on Assets (ROA) | -9.36% |
| Return on Capital (ROIC) | -15.98% |
| Revenue Per Employee | $869,084 |
| Profits Per Employee | -$194,919 |
| Employee Count | 273 |
| Asset Turnover | 1.18 |
| Inventory Turnover | 4.32 |
Taxes
In the past 12 months, Evolus has paid $220,000 in taxes.
| Income Tax | 220,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +80.09% in the last 52 weeks. The beta is 1.32, so Evolus's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | +80.09% |
| 50-Day Moving Average | 14.20 |
| 200-Day Moving Average | 12.73 |
| Relative Strength Index (RSI) | 61.79 |
| Average Volume (20 Days) | 606,052 |
Short Selling Information
The latest short interest is 4.77 million, so 7.55% of the outstanding shares have been sold short.
| Short Interest | 4.77M |
| Short Previous Month | 4.82M |
| Short % of Shares Out | 7.55% |
| Short % of Float | 10.66% |
| Short Ratio (days to cover) | 8.13 |
Income Statement
In the last 12 months, Evolus had revenue of $237.26 million and -$53.21 million in losses. Loss per share was -$0.90.
| Revenue | 237.26M |
| Gross Profit | 165.42M |
| Operating Income | -30.16M |
| Pretax Income | -52.99M |
| Net Income | -53.21M |
| EBITDA | -24.64M |
| EBIT | -30.16M |
| Loss Per Share | -$0.90 |
Full Income StatementBalance Sheet
The company has $93.67 million in cash and $126.75 million in debt, giving a net cash position of -$33.08 million or -$0.52 per share.
| Cash & Cash Equivalents | 93.67M |
| Total Debt | 126.75M |
| Net Cash | -33.08M |
| Net Cash Per Share | -$0.52 |
| Equity (Book Value) | 19.31M |
| Book Value Per Share | 0.31 |
| Working Capital | 104.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$17.20 million and capital expenditures -$959,000, giving a free cash flow of -$18.16 million.
| Operating Cash Flow | -17.20M |
| Capital Expenditures | -959,000 |
| Free Cash Flow | -18.16M |
| FCF Per Share | -$0.29 |
Full Cash Flow StatementMargins
Gross margin is 69.72%, with operating and profit margins of -12.71% and -22.43%.
| Gross Margin | 69.72% |
| Operating Margin | -12.71% |
| Pretax Margin | -22.34% |
| Profit Margin | -22.43% |
| EBITDA Margin | -10.39% |
| EBIT Margin | -12.71% |
| FCF Margin | -8.49% |
Dividends & Yields
Evolus does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.41% |
| Shareholder Yield | -4.41% |
| Earnings Yield | -5.13% |
| FCF Yield | -1.75% |
Analyst Forecast
The average price target for Evolus is $22.60, which is 36.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $22.60 |
| Price Target Difference | 36.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 27.72% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Evolus has an Altman Z-Score of -0.59 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.59 |
| Piotroski F-Score | 4 |